glp-1 atrial fibrillation Effects of Glucagon-Like Peptide-1 Receptor Agonists on Recurrence After Catheter Ablation Glucagon-like peptide 1 receptor agonists:

The research-supported minimum is 1.2 grams per kilogram of body weight per day

Cureus , 16 (7)

Another aspect of the present invention relates to an anion exchange chromatography process for purifying a GLP-1 peptide from a mixture comprising said peptide and related impurities, comprising the step of: separating said GLP-1 peptide and said related impurities of said mixture by elution in a solution consisting essentially of an organic modifier, water, optionally a salt component, and optionally a buffer, with a linear or step gradient or isocratically in salt component and/or with a linear or step pH-gradient or at a constant pH-value, wherein the pH-gradient or pH-value should be in the range where said peptide has a negative local or overall net charge different from the local or overall negative net charge of said related impurities so as to remove said related impurities

Administration: Both peptides are typically administered via subcutaneous injection

Phelps et al

Don't just look for 'Ozempic' or 'Mounjaro.' Look for the active ingredients, Semaglutide and Tirzepatide